| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 94.038 | 1.772 | 0 | 0 | 0 | 0 | 0 | 32.549 | 127.294 | 41.421 |
| Total Income - EUR | 95.204 | 1.772 | 1 | 0 | 459 | 0 | 148 | 32.549 | 127.296 | 41.426 |
| Total Expenses - EUR | 86.163 | 8.225 | 7.316 | 4.330 | 4.808 | 4.452 | 5.015 | 24.397 | 103.201 | 39.607 |
| Gross Profit/Loss - EUR | 9.042 | -6.454 | -7.315 | -4.330 | -4.349 | -4.452 | -4.867 | 8.152 | 24.095 | 1.819 |
| Net Profit/Loss - EUR | 7.296 | -6.507 | -7.315 | -4.330 | -4.363 | -4.452 | -4.871 | 7.833 | 22.818 | 1.451 |
| Employees | 3 | 1 | 2 | 0 | 0 | 0 | 0 | 3 | 1 | 1 |
Check the financial reports for the company - Oftamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.601 | 1.967 | 1.562 | 1.533 | 1.504 | 1.475 | 1.442 | 0 | 609 | 436 |
| Current Assets | 76.900 | 68.736 | 74.328 | 72.884 | 71.394 | 46.779 | 43.236 | 67.085 | 71.036 | 64.745 |
| Inventories | 20.866 | 20.185 | 27.942 | 27.240 | 26.712 | 18.580 | 18.168 | 63.006 | 65.775 | 63.000 |
| Receivables | 54.889 | 46.343 | 45.976 | 45.133 | 44.278 | 207 | 229 | 0 | 4.101 | 1.142 |
| Cash | 1.145 | 2.208 | 410 | 511 | 404 | 27.992 | 24.839 | 4.079 | 1.160 | 604 |
| Shareholders Funds | 30.429 | 23.657 | 15.941 | 11.318 | 6.736 | 2.157 | -2.762 | 5.062 | 23.822 | 25.140 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 49.071 | 47.047 | 59.949 | 63.099 | 66.162 | 46.097 | 47.441 | 62.023 | 47.823 | 40.041 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Oftamed Srl